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Abstract: The metabolic syndrome (MetS) represents a combination of cardiovascular risk determinants 
such as obesity, insulin resistance and lipid abnormalities such as hypertriglyceridemia, increased free fatty 
acids, high total cholesterol especially in correlation with low high-density-cholesterol and hypertension.  
Is well known that obesity is one of the most important factor in MetS pathogenesis. This study proposes 
to observe the metabolic and lesional changes in obese rats born from different feed parents and also their 
predisposition for MetS. We want to obtain an experimental model for MetS, and to see early biochemical and 
lesional changes. 
 
INTRODUCTION 
 
Obesity is becoming a global epidemic in both children and adults, and it is associated 
with numerous co-morbidities such as cardiovascular diseases (CVD), type 2 diabetes, 
hypertension, cancers. In fact, is an independent risk factor for CVD and CVD risks have been 
also documented in obese children, and is associated with reduced life expectancy. As a 
whole, overweight/obesity predispose or is associated with numerous cardiac complications 
such as coronary heart disease, heart failure, and sudden death through its impact on the 
cardiovascular system. Circulating mediators of inflammation participate in the mechanisms 
of vascular insult and atheromatous change, and many of these inflammatory proteins are 
secreted directly from adipocytes and adipose tissue-derived macrophages.  
Insulin resistance is associated with diabetes mellitus, ischemic heart disease, and 
hypertension both independently and as part of MetS. It is not clear, however, whether 
hypertriglyceridemia is caused by increased insulin resistance or insulin resis tance is caused 
by hypertriglyceridemia. Hypertriglyceridemia has the potential to cause insulin resistance by 
means of the glucose-fatty acid cycle by increasing fatty acid flux to the muscle and liver (8). 
The main mechanism by which insulin resistance could induce hypertriglyceridemia has been 
proposed to be hepatic insulin resistance to the inhibitory effect of insulin on VLDL-TG 
secretion. Furthermore, the inhibitory effect of insulin on fatty acid mobilization is reduced 
with insulin resistance, leading to increased flux of nonestenfied fatty acids to both muscle 
and liver. Increased flux of fatty acids to the liver is likely to lead to a further increase in 
secretion of VLDL (1, 4). 
Obesity increases the risk of cardiovascular disease in adults and has been strongly 
associated with insulin resistance in normoglycemic persons and in individuals with type 2 
diabetes (2, 9). The association of obesity with the insulin resistance syndrome (another name 
for metabolic syndrome) and cardiovascular risk is not only related to the degree of obesity 
but also seems to be critically dependent on body fat distribution. Thus, individuals with 
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greater degrees of central adiposity develop this syndrome more frequently than do those with 
a peripheral body fat distribution (7).  
The MetS is typically characterized by varying degrees of glucose intolerance, abnormal 
cholesterol and/or triglyceride levels, high blood pressure, and upper body obesity, all 
independent risk factors for cardiac disease. In fact, the presence of any one major feature 
alone substantially increases the risk of heart disease, but when they occur together the risk is 
magnified way out of proportion at the contribution of any one single factor. 
The intrauterine environment and early postnatal life are now generally accepted as 
important determinants of the risk of disease in adulthood. Low birth weight, a marker of 
intrauterine adversity, has consistently been associated with a variety of adult-onset diseases, 
including type 2 diabetes mellitus, essential hypertension, dyslipidemia, coronary artery 
disease, and cerebrovascular accidents. 
Hofman et al. observed that children 4 to 10 years of age who were born prematurely 
have an isolated reduction in insulin sensitivity suggests that they, like term infants who were 
small for gestational age, may be at increased risk for type 2 diabetes mellitus and other 
diseases of adulthood associated with insulin resistance. Children who were born at term but 
who were small for gestational age have a similar reduction in insulin sensitivity and have an 
increased risk of these adult-onset diseases (6).  
Thomas at al., show in a study that early life exposures during the prenatal period are 
associated with disturbances in glucose metabolism in midlife largely because they are 
associated with adiposity, which in turn influences risk of disturbances in glucose metabolism 
(11). 
High birth weight was found to be associated with increased risk of type 2 diabetes in 
later life to the same extent as low birth weight (5).  
These abnormalities were related to insulin resistance (IR) by cause-effect relationships 
and it was emphasized that IR alone is insufficient to alter glucose tolerance. IR and 
hyperinsulinemia are neither strictly necessary nor sufficient to alter lipid metabolism, blood 
pressure, or vascular function. Each of these systems is under multifactorial control, and 
defects in one or more steps of its effector pathway are necessary to drive the system out of 
balance (3). 
Observational data suggest an important role for factors predisposing for obesity and for 
insulin resistance in the pathogenesis of the MetS. Nevertheless, the question why some obese 
people develop the MetS and others don’t remains so far unanswered. Our current 
understanding suggests obesity and insulin resistance as the two major metabolic factors 
leading to a clustering of metabolic risk factors, which clinically result in the diagnosis MetS 
depending on the adjustment of the presumed but so far unknown metabolic susceptibility 
factor (10). 
 
MATERIAL AND METHOD 
 
Initially three lots of reproductive different nutrited Whistar rats were created: 
- Control lot (lot1) (n=8), female Whistar rats, age of aprox 100 days 
- Obese lot (lot 2) (n=8), female Whistar rats, age of aprox 100 days 
- Witness lot (lot 3) (n=8), female Whistar rats, age of aprox 100 days 
Males for reproduction were inserted at age of 120 days. Experimental lots was housed 
in cages, 5 rats in a cage (4 female and one male), on sawdust, 12 hours light and 12 hours 
dark, with water at discretion.  
The control lot was feed with the standard rat food with an approximate 25-30 g/animal.  
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The witness was fed with an mixed of breed, potatoes, apples, barley, looking to obtain 
the follow percent of nutrients: lipids 6%, proteins 16%, polizaharids 25%, fibre 15%, and a 
vitamin-mineral premix; food was administrated one time/day, approximate 20-25 g/animal. 
In obese lot food was made from by standard rat food mixed with pig fat, sugar and 
vitamin-mineral premix; food was administrated ad libidum.  
After the pregnancy was obtained, the males were removed. After birth in every female 
5 cubs was left alive and nursed, all the others were euthanized. 
Cubs from this different nutrited lots after wean (20 days) was fatted. From this age our 
study was made only in male cubs, making 4 lots by 15 animals: 
- Lot M – control with cubs born by rats from initial control lot (lot 1); 
- Lot H – fatted rats, cubs from obese lot; 
- Lot S – fatted rats, cubs from witness lot; 
- Lot MO – fatted rats, cubs from control lot. 
Cubs from all lots were weighted at birth and ages of 10, 20, 30, 50, 60, 100, 200, 300 
and 400 days. Also measurements of length, abdominal circumference were made.  
To appreciate obesity degree, results from those measurements were inserted in a body mass 
index (BMI) formula:  
BMI = [weight (g) + abdominal circumference (cm)]/length (cm) 
At age of 300days oral glucose tolerance test (OGTT) was made. 
At age of 400 days blood samples was taken to determine total lipids, triglycerides and 
cholesterol. After this all subjects were euthanized and samples from aorta, myocardium and 
adipose tissue for histopathological exam were ingathered. Samples was processed by paraffin 
technique and coloured Hematoxiline-Eosine (HE). 
Data were statistically processed by Student-t test. Were considerate valid value wit 
p<0,01.  
 
RESULTS AND DISCUTION 
 
Medium weight of reproductive lots is presented in tab. 1. 
 
Tab.1. 
 Medium weight of reproductive female when males were introduced fd – *negative 
Reproductive  females lots Medium weight 
(g) 
Statistic signification 
comparative with control lot 
Control (1) 185 - 
Obese (2) 278 p=0,0012 
Witness (3) 145 p*=0,0015 
 
Number of cubs and their body development were quantized. Were observed that cubs 
from witness and also from obese lots are fewer then cubs number from control lot.  
Cubs from control lot are uniform, they have a linearly grow and are statistically 
competitive with literature data. Cubs from obese lot have a statistically meaningful smaller 
weight comparative with control; this difference is recovered in time. In witness lot, cubs are 
in a small number in a female and with a smaller weight; weight difference is maintained or 
even amplified in time (Tab. 2). 
At 300 days weight, length and abdominal circumference were measured and a BMI vas 
calculated. Was observed a direct correlation between BMI and weight (Tab. 3).  
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Tab. 2. 
 Medium values of body weight (g). Standard deviation – st. dev.; p – statistical semnification of Student t test 
comparative with control lot; *negative; fd – with ought statistical signification.   
Age (days) – weight (g)  
Lot 
 
Var. 0 10 20 30 50 60 100 200 300 400 
media  5,86 17,1 33,9 48,4 88,4 97,6 104,2 170,2 183,6 305 
st. dev 0,48 1,36 1,68 5,16 6,30 7,33 9,38 15,44 16,83 19,68 
 
 
M p - control 
 
media  5,77 16,9 34,4 49 87,3 104 179,5 278,8 321,1 414 
st. dev 0,56 1,32 1,63 4,52 6,69 7,56 15,43 20,46 24,82 28,36 
 
 
MO p - 
control fd fd fd fd fd fd <0,001 <0,001 <0,001 
 
<0,001 
 
media  4,93 14,7 30,7 48,5 81,3 87 122,9 260,1 294,3 425,4 
st. dev 0,65 1,77 3,64 4,50 6,10 7,56 19,09 32,36 41,74 20,99 
 
 
 
H 
p - 
control 
<0,001 
* 
<0,001 
* fd fd fd fd <0,001 <0,001 <0,001 
 
<0,001 
 
media  4,71 8,46 21,4 23,2 33,5 51,8 87,2 215,3 295 352 
st. dev 0,49 1,80 5,43 5,58 9,94 8,83 15,50 26,70 31,5 32,51 
 
 
 
S 
p - 
control 
<0,001 
*
 
<0,001 
* 
<0,001 
* 
<0,001 
* 
<0,001 
* 
<0,001 
* 
<0,001 
* <0,001 <0,001 
 
<0,001 
 
Tab. 3.  
Medium weight and obesity degree, p – control statistic difference signification comparative with control 
lot (fd- without statistical signification) 
Nr. crt. Greutate Lungime CircumferinŃă 
abdominală 
Gradul de 
obezitate 
M 
Media 305 21,375 15,625 10,26 
StandDev 19,68 1,02 1,06 0,572 
p – control - - - - 
MO 
Media 414 22,70 17,875 18,52 
StandDev 28,36 0,75 0,64 1,70 
p – control < 0,01 f.d. < 0,01 < 0,01 
H 
Media 425,4 23,39 17,5 18,76 
StandDev 20,995 0,61 0,5 0,817 
p – control < 0,01 f.d. < 0,01 < 0,01 
S 
Media 352 21,2 18,2 17,45 
StandDev 32,51 0,83 0,758 1,271 
p – control < 0,01 f.d. < 0,01 < 0,01 
 
Oral glucose tolerance test (OGTT) was made. It can be observed that glycaemia a jeun 
is rise in obese lots comparative with control. Also in control lot glycaemia at 2 h rich the 
initial level during obese lots remains hi (Fig. 1).  
Initial and at 2 h glycaemia data, obtained after OGTT are positive correlated with 
obesity degree. In obese rats was observed in OGTT a moderate glucose intolerance 
comparative with control lot that had physiologic values (Fig. 2).  
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Fig. 1. Glycaemia evolution in OGTT   Fig. 2. IMC – Glycaemia correlation 
 
At age of 400 days, blood samples were engendered and total lipids, triglycerides and 
cholesterol. Was observed hi levels of all measured components in obese subjects but 
differences were more pregnant in lots H and S.  
 
Tab. 4. Total lipids, triglycerides, cholesterol in correlation with BMI at age of 400  
Lot Total lipids 
(mg/dl) 
Triglycerides 
(mg/dl) 
Cholesterol 
(mg/dl) 
BMI 
M 261,5 98 39,8 10,26 
MO 293,4 75 52 18,52 
H 641,36 374,8 108,6 18,762 
S 477,02 191,6 66,2 17,45 
 
At vascular level some early modification were observe in all obese lots. We observed intimal 
thickness (Fig. 3), presence in tunica media of some lipoid cells with a foamy aspect (Fig. 4). 
 
 
Fig. 3. Intimal thickness HE x10       Fig. 4. Foamy cells in arterial media HE x40 
 
How our results show, in this work we have reproduced an experimental model of 
insulin resistance in obese Whistar rats. OGTT measure organism possibility to use glucose. 
By measuring glycaemia before oral administration of a standard glucose quantity and after 
this administration in regulate intervals, it can be appreciate cells sensitivity degree to insulin. 
Results of OGTT showed an increase insulin tolerance in obese rats. Glycaemia a jeun and at 
2 hours from obese rats show a statistical significantly differences (p<0,01) comparative with 
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control lot. These values are positively correlated with BMI. In concordance with WHO 
standards, rats from obese lots can be situated, after OGTT results, in IFG (Impaired fasting 
glycaemia) or even in IGT (impaired glucose tolerance) categories. All these, especially 
because physiological values of glycaemia in rats (65 – 80 mg/dl) is smaller than human 
values.  
From literature data rise that central obesity and metabolic syndrome incidence is bigger 
in persons with a low birth weight. From this idea we try to obtain rats cubs with a low birth 
weight and observing the development, metabolic and lesional changes. 
 
CONCLUSIONS 
 
• Our results show the apparition of metabolic and lesional changes similar with those form 
metabolic syndrome in human. 
• From witness and also from obese females, cubs hade low birth weight; we can conclude 
that precarious nutrition and also obesity are factors that damage cubs quality.   
• Differences between cubs from witness and obese mothers are statistically significant 
reported to control lot, so can be used to appreciate their obesity predisposition.  
• BMI is positively correlated with insulin resistance and also with total lipids, triglycerides 
and cholesterol values. 
• Total lipids, triglycerides and cholesterol are much higher in cubs born from obese and 
witness parents. 
• Insulin resistance (determinate by OGTT) can be used in early diagnose of metabolic 
syndrome. 
• Our experimental model can be used to study cardiovascular changes from obesity.  
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